These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 25382512

  • 1. Eccrine syringofibroadenomatosis of the reactive subtype occurring in chronic poorly-controlled psoriasis.
    Heng YK, Pan JY, Tan SH, Tey HL.
    Indian J Dermatol Venereol Leprol; 2014; 80(6):534-6. PubMed ID: 25382512
    [Abstract] [Full Text] [Related]

  • 2. Reactive Eccrine Syringofibroadenomatosis Associated With Venous Leg Ulcers: A Case Report and Literature Review.
    Tedbirt B, Carvalho P, Boulard C, Tetart F, Deschamps-Huvier A, Chenal P, Courville P, Cellier L, Joly P.
    Int J Low Extrem Wounds; 2023 Mar; 22(1):135-138. PubMed ID: 33076722
    [Abstract] [Full Text] [Related]

  • 3. Eccrine syringofibroadenoma arising in peristomal skin: a report of two cases.
    Clarke LE, Ioffreda M, Abt AB.
    Int J Surg Pathol; 2003 Jan; 11(1):61-3. PubMed ID: 12598924
    [Abstract] [Full Text] [Related]

  • 4. Reactive eccrine syringofibroadenomatosis associated with venous stasis and plaque psoriasis.
    Tey HL, Tan SH.
    Acta Derm Venereol; 2008 Jan; 88(1):82-4. PubMed ID: 18176766
    [No Abstract] [Full Text] [Related]

  • 5. Eccrine syringofibroadenomatosis in two patients with bullous pemphigoid.
    Nomura K, Hashimoto I.
    Dermatology; 1997 Jan; 195(4):395-8. PubMed ID: 9529566
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Solitary eccrine syringofibroadenoma (or eccrine syringofibroadenomatous hyperplasia?) and diabetic polyneuropathy.
    Gambini C, Rongioletti F, Semino MT, Rebora A.
    Dermatology; 1996 Jan; 193(1):68-9. PubMed ID: 8864629
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eccrine syringofibroadenoma: report of a case and analysis of cytokeratin expression.
    Takeda H, Mitsuhashi Y, Yoshikawa K, Katagata Y, Kondo S.
    Dermatology; 1998 Jan; 196(2):242-5. PubMed ID: 9568415
    [Abstract] [Full Text] [Related]

  • 18. [Eccrine syringofibroadenoma. Report of a case].
    Grimaud H, Le Gall F, Adamski H, Wechsler J, Chevrant-Breton J.
    Ann Pathol; 1997 Mar; 17(1):52-4. PubMed ID: 9162160
    [Abstract] [Full Text] [Related]

  • 19. Solitary eccrine syringofibroadenoma with prominent plasma cell infiltration.
    Kim JY, Kim YC, Lee ES.
    J Dermatol; 2007 Feb; 34(2):138-41. PubMed ID: 17239154
    [Abstract] [Full Text] [Related]

  • 20. Reactive eccrine syringofibroadenoma: an emerging subtype.
    French LE.
    Dermatology; 1997 Feb; 195(4):309-10. PubMed ID: 9529546
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.